Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Protease Inhibitor Cocktail for Mitochondrial Assays
2026-08-07
Learn how an EDTA-free protease inhibitor workflow can preserve mitochondrial, migrasome, and phosphorylation-sensitive readouts in cancer research. Practical dilution guidance, assay-specific controls, and troubleshooting help distinguish true biology from sample degradation.
-
AICAR Phosphate (Acadesine): Mechanism and Strategy in B-CLL
2026-08-07
This thought-leadership article bridges cutting-edge mechanistic insight and actionable protocol guidance for translational researchers leveraging AICAR phosphate (Acadesine) in cancer and neuroimmune research. Anchored by new evidence linking AMPK signaling to apoptosis and CNS barrier integrity, the discussion integrates rigorous experimental data, workflow recommendations, and strategic vision for AMPK-targeted therapies. It differentiates itself by weaving together oncology, neurobiology, and immune modulation domains, highlighting APExBIO's reagent excellence for high-impact, reproducible science.
-
Letrozole: Non-Steroidal Aromatase Inhibitor in Research Wor
2026-08-06
Letrozole stands out as a precise, potent tool for dissecting estrogen-dependent mechanisms in breast cancer and neuroendocrine research. This guide delivers actionable workflow enhancements, troubleshooting strategies, and protocol advice to maximize reproducibility and scientific impact.
-
KU-55933: ATM Kinase Inhibitor for Advanced DNA Damage Resea
2026-08-06
KU-55933 empowers precision DNA damage response studies with nanomolar specificity, enabling direct manipulation of ATM-driven pathways in cancer and genome integrity research. This article details step-by-step experimental workflows, real-world troubleshooting, and how new insights on cGAS and L1 retrotransposition can be practically leveraged with this potent ATM kinase inhibitor.
-
CircRNA hsa_circ_0136666 Drives Gastric Cancer Immune Escape
2026-08-05
This study uncovers hsa_circ_0136666 as a central regulator of gastric cancer progression and immune evasion, acting through the miR-375/PRKDC axis to stabilize PD-L1. The findings highlight a novel mechanism of tumor immune escape and suggest new targets for enhancing anti-PD-L1 therapy efficacy.
-
KU-55933: Applied Protocols for ATM Kinase Inhibitor Workflo
2026-08-05
KU-55933 enables precise ATM kinase inhibition for dissecting DNA damage response, cell cycle arrest, and cancer cell metabolism. This guide provides stepwise protocols, real-world troubleshooting, and actionable insights—bridging best practices with innovative iPSC-based screening platforms.
-
BRCA2-Dependent Repair of Olaparib-Induced Nascent Strand Ga
2026-08-04
This study uncovers a BRCA2-dependent mechanism that facilitates nascent DNA strand maturation during replication, even in the presence of PARP inhibition by Olaparib. The findings clarify how BRCA1/2 and RAD51 orchestrate the repair of DNA gaps, with implications for understanding synthetic lethality and refining BRCA-associated cancer targeted therapy.
-
NU7441 (KU-57788): Precision DNA-PK Inhibition for Cell Cycl
2026-08-04
Explore how NU7441 (KU-57788) advances DNA repair research with nanomolar precision as a DNA-PK inhibitor. This article uniquely delves into its mechanistic impact on cell cycle regulation and the practical implications for oncology research.
-
EdU Imaging Kits (Cy5): Precision Cell Proliferation Analysi
2026-08-03
EdU Imaging Kits (Cy5) empower researchers with high-sensitivity, morphology-preserving detection of S-phase DNA synthesis, outperforming traditional BrdU assays in both workflow efficiency and data quality. Their compatibility with fluorescence microscopy and flow cytometry unlocks advanced applications in tumor modeling, genotoxicity screening, and pharmacodynamic research.
-
Trilaurin (Glycerol Tridodecanoate): Applied Workflows & Tro
2026-08-03
Trilaurin stands out as a versatile, inert lipid excipient for solid lipid microparticles, enabling reproducible results in oral peptide drug delivery and biocatalytic synthesis. Its unique lack of adjuvant activity in hypersensitivity models and robust performance in non-aqueous protocols set it apart for pharmaceutical and biomedical research workflows.
-
Stat3 Drives Fyn Kinase-Mediated Neurodegeneration in Zebraf
2026-08-02
This study reveals that Stat3 signaling is a crucial mediator of Fyn kinase-induced dopaminergic neuron loss and microglial activation in a zebrafish model. By dissecting the Fyn-Stat3-NF-κB axis, the research identifies new molecular targets for functional gene studies in neurodegeneration and neuroinflammation.
-
CKI 7 Dihydrochloride Enables Precision in CK1 Pathway Disse
2026-08-01
Explore how CKI 7 dihydrochloride, a selective Casein kinase 1 inhibitor, advances research into Wnt signaling and NSCLC metastasis. This article offers new analytical depth and practical guidance for advanced cancer biology and circadian rhythm studies.
-
Chlorpromazine Hydrochloride in Antipsychotic Research Workf
2026-07-31
Chlorpromazine hydrochloride is pivotal for dissecting dopamine receptor signaling in both neuropsychiatric and hepatic nanoparticle studies. This article unpacks advanced experimental workflows, troubleshooting guidance, and protocol enhancements—bridging CNS research with emerging insights on liver cell interactions.
-
gamma-Glu-Cys (γ-Glu-Cys): Practical Guidance for Lab Use
2026-07-31
gamma-Glu-Cys (γ-Glu-Cys) is a critical substrate for glutathione synthetase activity assays and thiol-reactive peptide synthesis workflows. It enables precise control over glutathione metabolism research but is not designed for diagnostic or clinical applications. Researchers should use freshly prepared solutions and observe stability limitations to maintain data quality.
-
Nuclear cGAS Restricts L1 Retrotransposition via TRIM41-Medi
2026-07-30
This study uncovers a novel function of nuclear cGAS in repressing LINE-1 (L1) retrotransposition through the promotion of TRIM41-mediated ubiquitination and degradation of ORF2p. These findings clarify a previously underexplored layer of genome stability maintenance with implications for aging and cancer biology.